MARKETS / BALCAO / STME
BALCAO · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · SMALL CAP

Stimcell Energetics Inc. STME

15 fiscal years on record · USD · FY2024 reported
SEC FILINGS ONLY
EPS · FY24
Dividend / sh · FY24
Payout · FY24
ROE · FY24
Net margin · FY24
Dividend coverage
Advertisement
AdSense · Leaderboard 728×90320×100
Result
Revenue, FY2024 · full 15-year series below
Revenue Net income
2.5e-055e-057.5e-050.0001-0.0201020132016201920222024
2.5e-055e-057.5e-050.0001-0.02015201820212024

Per share
Diluted EPS, FY2024
EPS
0.40.81.2201020132016201920222024
0.40.81.22015201820212024

The company pays no cash dividend.

Profitability
Return on equity, FY2024
ROE
0.250.50.751201020132016201920222024
0.250.50.7512015201820212024
Operating margin
Net margin
Return on assets-1681.8%

Returned to shareholders
returned in FY2024 · dividends + net buybacks
Dividends paid
Net buybacks
Share of profit
Consecutive raises

Growth
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs

Compound annual rates per period — left blank where the series crosses a loss.

Share base
Shares outstanding, FY2024
0.030.04201020132016201920222024
0.030.042015201820212024
Change, 5 years
Change, 10 years

A share split breaks the comparison across the period, so we leave it out.

Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 21,222.00
total assets, end of FY2024
Total assetsUSD 21,222.00
CashUSD 14,581.00

History
15 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
Revenue $B
·
0.0
0.0
·
·
0.0
0.0
·
0.0
0.0
·
·
·
0.0
0.0
Operating income $B
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
EBITDA $B
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Income tax $B
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Net income $B
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
EPS, diluted $
·
·
·
·
−0.02
−0.02
−0.02
−0.04
−0.03
−0.07
−0.03
0.00
0.00
0.00
0.00
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
ROE %
·
·
·
·
·
·
·
·
·
·
·
·
−284.0
−428.9
·
Shares out B
·
·
·
·
·
·
·
0.04
0.04
0.03
·
·
·
·
·

Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.

How we verifyAUDITED
39 of 39
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity

Every figure was compared against the original statement: 0 failures and 0 presentation gaps.

What we don’t show

We’d rather say what’s missing than fill the gap with an estimate.

P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed